Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus | Zendy

M. Barcia-Macay | Zendy; Sandrine Lemaire | Zendy; MariePaule MingeotLeclercq | Zendy; Paul M. Tulkens | Zendy; Françoise Van Bambeke | Zendy

Open Access

Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus

Author(s) -

M. Barcia-Macay,

Sandrine Lemaire,

MariePaule MingeotLeclercq,

Paul M. Tulkens,

Françoise Van Bambeke

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl424

Subject(s) - vancomycin , staphylococcus aureus , microbiology and biotechnology , extracellular , methicillin resistant staphylococcus aureus , chemistry , antibacterial agent , intracellular , cmax , antibiotics , biology , bacteria , pharmacology , pharmacokinetics , biochemistry , genetics

To compare extracellular and intracellular activities of telavancin (versus vancomycin) against Staphylococcus aureus (MSSA, MRSA, VISA and VRSA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research